Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Nucleic acid production196.35M75.75%
Biologics safety testing62.84M24.25%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
North America127.09M49.03%
Asia Pacific89.38M34.48%
Europe, the Middle East and Africa42.06M16.23%
Latin and Central America662K0.26%